Found 7 matching trials
A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP PHASE2 This international, multi-centre, double-blind vaccine study is a three-arm...
Show More Location
MRC/UVRI and LSHTM Uganda Research Unit
Learn More & Join Trial
Clinical Trial of HIV Vaccine Combinations in Healthy Men and Women PHASE1 A Phase I Single-Blind randomised trial investigating immunisation strategi...
Show More Location
NIHR Imperial Clinical Research Facility
Learn More & Join Trial
Safety and Immunogenicity of HIV DNA-C CN54ENV and Recombinant HIV CN54gp140 Vaccines in Healthy Volunteers PHASE1 CUTHIVAC002 is a randomised Phase I study aimed at exploring the safety and...
Show More Location
NIHR/Wellcome Trust Imperial Clinical Research Facility, Hammersmith Hospital, Imperial College Healthcare NHS Trust
Learn More & Join Trial
The Safety and Immunogenicity of a Potential HIV Vaccine PHASE1 The potential HIV vaccine has two components: a protein immunogen based on ...
Show More Location
NIHR/Wellcome Trust Imperial Clinical Research Facility, Hammersmith Hospital, Imperial College Healthcare NHS Trust
Learn More & Join Trial
Reactogenicity and Immunogenicity of Cervico-vaginal CN54gp140-hsp70 Conjugate Vaccine PHASE1 A vaccine to prevent infection with the Human Immunodeficiency Virus (HIV) ...
Show More Location
St George's - University of London
Learn More & Join Trial
A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults PHASE1 EHVA P01 is an international, phase I, prophylactic HIV vaccine trial to ev...
Show More Learn More & Join Trial
Reactogenicity and Immunogenicity of Vaginal CNgp140 PHASE1 To determine the local (cervico-vaginal) and systemic (whole body) safety o...
Show More Location
St George's Vaccine Institute
Learn More & Join Trial